CoChat

Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats

Open access
Muthukumaran, Jayachandran, Srinivasan, Subramani, Venkatesan, Rantham Subramaniyam, Ramachandran, Vinayagam, Muruganathan, Udaiyar · 2013 · Journal of Acute Disease
Cited by 122

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

To evaluate the antidiabetic effect of syringic acid, a natural phenolic compound on the levels of glycoprotein components in plasma and tissues of alloxan induced diabetic rats. Diabetes was induced in male Wistar rats by a single intraperitoneal injection of alloxan (150 mg/kg b.w). Syringic acid (50 mg/kg b.w) was administered orally for 30 d. The effects of syringic acid on plasma glucose, insulin, C-peptide, plasma and tissue glycoproteins were studied. Oral administration of syringic acid (50 mg/kg b.w) for 30 d positively modulates the glycemic status in alloxan induced diabetic rats. The levels of plasma glucose were decreased with significant increase of plasma insulin and C-peptide level. The altered levels of plasma and tissue glycoprotein components were restored to near normal. No significant changes were noticed in normal rats treated with syringic acid. The present findings suggest that syringic acid can potentially ameliorate glycoprotein components abnormalities in addition to its antidiabetic effect in experimental diabetes, further clinical studies are required to evaluate the use of syringic acid as an effective therapeutic agent for the treatment of diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2221-6189(13)60149-3

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 28

  1. Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract, 94, 311, 10.1016/j.diabres.2011.10.029 · DOI · Paper page
  2. Mittal, 1996, Changes in tubular membrane glycosylation in diabetic insulin and thyroxin treated rat kidneys, Ind J Exp Biol, 34, 782
  3. Peppa, 2009, Advanced glycoxidation products and impaired diabetic wound healing, Wound Repair Regen, 17, 461, 10.1111/j.1524-475X.2009.00518.x · DOI · Paper page
  4. Pari, 2010, Protective role of coumarin on plasma and tissue glycoprotein components in streptozotocin-nicotinamide induced hyperglycemic rats, Int J Biol Med Res, 1, 61
  5. Wangchuka, 2011, Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities, J Ethnopharmacol, 137, 730, 10.1016/j.jep.2011.06.032 · DOI
  6. Nadeem, 2011, Ameliorative effects of Alpinia calcarata Roscoe in alloxan-induced diabetic rats, Dig J Nanomater Bios, 6, 991
  7. Niebes, 1972, Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects, Clin Chim Acta, 42, 399, 10.1016/0009-8981(72)90105-2 · DOI · Paper page
  8. Warren, 1959, The thiobarbituric acid assay of sialic acids, J Biol Chem, 234, 1971, 10.1016/S0021-9258(18)69851-5 · DOI · Paper page
  9. Wagner, 1979, A more sensitive assay discriminating galactosamine and glucosamine in mixtures, Anal Biochem, 94, 394, 10.1016/0003-2697(79)90379-8 · DOI · Paper page
  10. Dische, 1948, A specific color reaction of methylpentoses and a spectrophotometric micro method for their determination, J Biol Chem, 175, 595, 10.1016/S0021-9258(18)57178-7 · DOI · Paper page
  11. Duncan, 1957, Multiple ranges tests for correlated and heteroscedastic means, Biometrics, 13, 359, 10.2307/2527799 · DOI · Paper page
  12. Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol Res, 50, 537, 10.33549/physiolres.930111 · DOI · Paper page
  13. Pari, 2009, Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats, Chem Biol Interact, 181, 292, 10.1016/j.cbi.2009.07.018 · DOI
  14. Wang, 2012, Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C peptide assay, Diabetes Care, 35, 465, 10.2337/dc11-1236 · DOI · Paper page
  15. Wahren, 2004, C-peptide: new findings and therapeutic implications in diabetes, Clin Physiol Funct Imaging, 24, 180, 10.1111/j.1475-097X.2004.00558.x · DOI
  16. Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a · DOI · Paper page
  17. Saravananan, 2010, Antidiabetic effect of S allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes, Phytomedicine, 17, 1086, 10.1016/j.phymed.2010.04.008 · DOI
  18. Pari, 2010, Preventive effect of diosmin, a bioflavonoid, on glycoprotein changes in streptozotocin-nicotinamide-induced type 2 diabetic rats, In J Pharm Sci Res, 10, 89
  19. Sundaram, 2012, Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components, Phytomedicine, 19, 211, 10.1016/j.phymed.2011.10.006 · DOI
  20. Shao, 2005, Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio, Diabetes, 54, 976, 10.2337/diabetes.54.4.976 · DOI · Paper page
  21. Shah, 2009, Therapeutic strategies in the treatment of diabetic nephropathy-a translational medicine approach, Curr Med Chem, 16, 997, 10.2174/092986709787581897 · DOI
  22. Kikkawa, 2003, Progression of diabetic nephropathy, Am J Kidney Dis, 41, 19, 10.1053/ajkd.2003.50077 · DOI · Paper page
  23. Spiro, 1971, Effect of diabetes on the biosynthesis of the renal glomerular basement membrane. Studies on the glycosyl transferase, Diabetes, 20, 641, 10.2337/diab.20.10.641 · DOI
  24. Buse, 2006, Hexosamines, insulin resistance, and the complications of diabetes: current status, Am J Physiol Endocrinol Metab, 290, 1, 10.1152/ajpendo.00329.2005 · DOI · Paper page
  25. Pari, 2009, Protective role of tetrahydrocurcumin and chlorogenic acid on glycoprotein changes in streptozotocin-nicotinamide-induced diabetic rats, J Pharm Sci Res, 1, 173
  26. Ramkumar, 2007, Ethanol extract of Gymnema montanum leaves reduces glycoprotein components in experimental diabetes, Nutr Res, 27, 97, 10.1016/j.nutres.2006.12.010 · DOI
  27. Ciftci, 2010, Effect of fluoride exposure on serum glycoprotein pattern and sialic acid level in rabbits, Biol Trace Elem Res, 133, 51, 10.1007/s12011-009-8563-y · doi:10.1007/s12011-009-8563-y
  28. Gavella, 2003, Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients, Acta Diabetol, 40, 95, 10.1007/s005920300012 · doi:10.1007/s005920300012

Cited by

See all 122

Metadata

Authors
Muthukumaran, J., Srinivasan, S., Venkatesan, R. S., Ramachandran, V., & Muruganathan, U.
Venue
Journal of Acute Disease
Published
2013
Volume
2
Issue
4
Pages
304-309
ISSN
2221-6189 (ISSN-L)
OpenAlex
W1991025907
Cited by
122
References
4
FWCI
2.59
Type
journal article
Language
en
Open access
diamond
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. https://app.cochat.ai/papers/10.1016/s2221-6189(13)60149-3
The paper
Muthukumaran, J., Srinivasan, S., Venkatesan, R. S., Ramachandran, V., & Muruganathan, U. (2013). Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. Journal of Acute Disease. https://doi.org/10.1016/s2221-6189(13)60149-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.